Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DOCETAXEL | ACCORD HLTHCARE | N-201195 RX | 2012-04-20 | 3 products, RLD, RS |
DOCETAXEL | Allergan | N-203551 RX | 2013-04-12 | 4 products |
DOCETAXEL | AVYXA HOLDINGS | N-215813 PEND | 2022-11-22 | 3 products, RLD |
DOCETAXEL | Hospira | N-022234 RX | 2011-03-08 | 6 products, RLD, RS |
DOCETAXEL | Sandoz | N-201525 RX | 2011-06-29 | 3 products |
TAXOTERE | Sanofi | N-020449 RX | 2010-08-02 | 3 products, RLD, RS |
DOCETAXEL | Shilpa Medicare | N-205934 RX | 2015-12-22 | 3 products, RLD, RS |
DOCETAXEL | sparc | N-022534 RX | 2019-01-08 | 3 products |
Brand Name | Status | Last Update |
---|---|---|
docetaxel | ANDA | 2024-01-29 |
docetaxel anhydrous | ANDA | 2023-07-10 |
Code | Description |
---|---|
J9171 | Injection, docetaxel, 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 72 | 296 | 176 | 25 | 57 | 585 |
Non-small-cell lung carcinoma | D002289 | — | — | 86 | 273 | 116 | 8 | 23 | 452 |
Prostatic neoplasms | D011471 | — | C61 | 95 | 226 | 63 | 4 | 27 | 371 |
Neoplasms | D009369 | — | C80 | 157 | 61 | 12 | 2 | 12 | 216 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | 24 | 127 | 32 | 1 | 14 | 171 |
Head and neck neoplasms | D006258 | — | — | 28 | 67 | 11 | 1 | 6 | 101 |
Esophageal neoplasms | D004938 | — | C15 | 19 | 50 | 13 | 4 | 9 | 82 |
Squamous cell carcinoma of head and neck | D000077195 | — | — | 22 | 58 | 14 | 1 | 2 | 81 |
Castration-resistant prostatic neoplasms | D064129 | — | — | 22 | 44 | 11 | 2 | 6 | 74 |
Adenocarcinoma | D000230 | — | — | 8 | 52 | 12 | 1 | 4 | 70 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 33 | 100 | 24 | — | 9 | 148 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 24 | 42 | 8 | — | 5 | 73 |
Nasopharyngeal neoplasms | D009303 | — | — | — | 21 | 17 | — | 10 | 47 |
Nasopharyngeal carcinoma | D000077274 | — | — | — | 17 | 18 | — | 10 | 45 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 12 | 34 | 1 | — | 2 | 43 |
Sarcoma | D012509 | — | — | 17 | 24 | 4 | — | — | 39 |
Triple negative breast neoplasms | D064726 | — | — | 12 | 25 | 6 | — | 2 | 34 |
Urinary bladder neoplasms | D001749 | — | C67 | 8 | 17 | 3 | — | 2 | 27 |
Fallopian tube neoplasms | D005185 | — | — | 9 | 10 | 8 | — | — | 25 |
Urologic neoplasms | D014571 | — | C64-C68 | 11 | 15 | 3 | — | 1 | 23 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colorectal neoplasms | D015179 | — | — | 13 | 8 | — | — | 2 | 15 |
Melanoma | D008545 | — | — | 8 | 7 | — | — | 1 | 13 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | 6 | — | — | 1 | 7 |
Kidney neoplasms | D007680 | EFO_0003865 | C64 | 4 | 2 | — | — | 1 | 6 |
Biliary tract neoplasms | D001661 | — | C24.9 | — | 4 | — | — | 1 | 5 |
Gallbladder neoplasms | D005706 | EFO_0004606 | C23 | 1 | 3 | — | — | 1 | 5 |
Cholangiocarcinoma | D018281 | — | C22.1 | 1 | 5 | — | — | — | 5 |
Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | 4 | — | — | — | 4 |
Lymphoma | D008223 | — | C85.9 | 3 | 2 | — | — | — | 4 |
Ewing sarcoma | D012512 | EFO_0000173 | — | — | 4 | — | — | — | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myeloid leukemia acute | D015470 | — | C92.0 | 2 | — | — | — | — | 2 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 2 | — | — | — | — | 2 |
Pharmacokinetics | D010599 | — | — | 1 | — | — | — | 1 | 2 |
Hematologic neoplasms | D019337 | — | — | 2 | — | — | — | — | 2 |
Colonic neoplasms | D003110 | — | C18 | 2 | — | — | — | — | 2 |
Liver diseases | D008107 | HP_0002910 | K70-K77 | 1 | — | — | — | — | 1 |
Renal insufficiency | D051437 | HP_0000083 | N19 | 1 | — | — | — | — | 1 |
Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 1 | — | — | — | — | 1 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 1 | — | — | — | — | 1 |
Chondrosarcoma | D002813 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | — | — | — | 2 | 2 |
Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 1 | 1 |
Breast cancer lymphedema | D000072656 | — | — | — | — | — | — | 1 | 1 |
Taste disorders | D013651 | — | — | — | — | — | — | 1 | 1 |
Dysgeusia | D004408 | — | R43.2 | — | — | — | — | 1 | 1 |
Ageusia | D000370 | EFO_1001758 | — | — | — | — | — | 1 | 1 |
Observation | D019370 | — | — | — | — | — | — | 1 | 1 |
Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | — | — | — | 1 | 1 |
Nose neoplasms | D009669 | — | C76.0 | — | — | — | — | 1 | 1 |
Neuralgia | D009437 | EFO_0009430 | — | — | — | — | — | 1 | 1 |
Drug common name | Docetaxel |
INN | docetaxel |
Description | Docetaxel anhydrous is a tetracyclic diterpenoid that is paclitaxel with the N-benzyloxycarbonyl group replaced by N-tert-butoxycarbonyl, and the acetoxy group at position 10 replaced by a hydroxy group. It has a role as an antineoplastic agent, a photosensitizing agent and an antimalarial. It is a tetracyclic diterpenoid and a secondary alpha-hydroxy ketone. It derives from a hydride of a taxane. |
Classification | Small molecule |
Drug class | antineoplastics, taxane derivatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C.O.O.O |
PDB | — |
CAS-ID | 148408-66-6 |
RxCUI | — |
ChEMBL ID | CHEMBL3545252 |
ChEBI ID | 59809 |
PubChem CID | 148124 |
DrugBank | DB01248 |
UNII ID | 699121PHCA (ChemIDplus, GSRS) |